有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Penciclovir;BRL-39123;Denavir;Vectavir
Chemical Name 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine
CAS 39809-25-1
Related CAS 97845-62-0 (Na salt)
Formula C10H15N5O3
Structure
Formula Weight 253.26275
Stage 上市-1996
Company Novartis (Proprietary), GlaxoSmithKline (Originator), CollaGenex (Marketer)
Activity/Mechanism Anti-Herpes Labialis Drugs, Anti-Herpes Simplex Virus Drugs, Anti-Herpes Virus Drugs, ANTIINFECTIVE THERAPY, Antiviral Drugs
Syn. Route 2
Route 1
the synthesis of penciclovir by two related ways has been reported:1) the reaction of 2-(hydroxymethyl)butane-1,4-diol (i) with formaldehyde (or an aldehyde such as trimethylacetaldehyde) (ii) by means of h2so4 (or p-toluenesulfonic acid, tsoh) gives the dioxane (iii), which by reaction first with methanesulfonyl chloride and triethylamine and then with nai in acetone affords the corresponding 5-(2-iodoethyl)-1,3-dioxane (iv). the reaction of (iv) with 2-amino-6-chloropurine (v) by means of k2co3 in dmf gives the corresponding condensation product (vi), which is finally hydrolyzed and deprotected with refluxing 2m aqueous hcl.2) the reaction of triol (i) with 2,2-dimethoxypropane (vii) by means of tsoh gives the corresponding 1,3-dioxane (viii), which by reaction with triphenylphosphine and cbr4 is converted to the 5-(2-bromoethyl) derivative (ix). the reaction of (ix) with the purine (v) by means of k2co3 as before affords the corresponding condensation product (x), which is hydrolyzed and deprotected with 2m hcl as before.
List of intermediates No.
4-nitrobenzyl (5r,6s)-3-[(diphenoxyphosphoryl)oxy]-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (i)
4-nitrobenzyl (2s,4s)-2-[(dimethylamino)carbonyl]-4-sulfanyl-1-pyrrolidinecarboxylate (iiia)
1-(chloromethyl)-4-nitrobenzene (iva)
(2s,4r)-4-hydroxy-1-[[(4-nitrobenzyl)oxy]carbonyl]-2-pyrrolidinecarboxylic acid (v)
2-(4-methoxybenzyl) 1-(4-nitrobenzyl) (2s,4r)-4-hydroxy-1,2-pyrrolidinedicarboxylate (via)
2-(4-methoxybenzyl) 1-(4-nitrobenzyl) (2s,4s)-4-(acetylsulfanyl)-1,2-pyrrolidinedicarboxylate (vii)
4-nitrobenzyl (2s,4s)-4-(acetylsulfanyl)-2-[(dimethylamino)carbonyl]-1-pyrrolidinecarboxylate (viii)
4-nitrobenzyl (5s,6s)-3-[((3s,5s)-5-[(dimethylamino)carbonyl]-1-[[(4-nitrobenzyl)oxy]carbonyl]pyrrolidinyl)sulfanyl]-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (ix)
n-[(benzyloxy)carbonyl]valine (x)
Reference 1:
    grinter, t.j.; choudary, b.m.; macbeath, f.s.; parratt, m.j.; geen, g.r.; influence of remote structure upon regioselectivity in the n-alkylation of 2-amino-6-chloropurine: application to the synthesis of penciclovir. nucleosides nucleotides 1994, 13, 4, 979.

Route 2
this compound has been obtained by two similar ways:1) the reaction of 6-chloropurine-2-amine (i) with 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione (ii) by means of k2co3 in dmf gives the expected condensation product (iii), which is methanolized with hcl/methanol yielding 2-[2-(2-amino-6-methoxypurin-9-yl)ethyl]malonic acid dimethyl ester (iv). the reduction of (iv) with nabh4 in tert-butanol/methanol affords the corresponding diol (v), which is finally converted into pecnciclovir by hydrolysis with 2n naoh.2) the reaction of purine (i) with 3-bromopropane-1,1,1-tricarboxylic acid triethyl ester (vi) by means ofk2co3 in dmf gives the expected condensation product (vii), which is partially decarboxylated with sodium methoxide in methanol yielding 2-[2-(2-amino-6-chloropurin-9-yl)ethyl]malonic acid diethyl ester (viii). the reduction of (viii) with nabh4 in tert-butanol/methanol followed by acetylation with acetic anhydride affords the corresponding diol diacetate (ix), which is finally converted into penciclovir by hydrlysis with 2n hcl.
List of intermediates No.
4-(4-pyridinyl)heptanedioic acid (ii)
4-bromopyridine (i)
8-(4-pyridinyl)-1,4-dioxaspiro[4.5]decan-8-ol (iii)
4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)pyridine (vi)
(1r,5r)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene (vii)
(1r,3as,3br,5as,6as,7as,8as,8bs,10as)-1-hydroxy-8a,10a-dimethylhexadecahydro-2h-cyclopenta[7,8]phenanthro[2,3-b]oxiren-2-one (viii)
(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-10,13-dimethyl-2,16-di(1-piperidinyl)hexadecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol (ix)
(e)-1,4-dichloro-2-butene (iv)
diethyl 2-vinyl-1,1-cyclopropanedicarboxylate (v)
Reference 1:
    jarvest, r.l.; harnden, m.r.; an improved synthesis of the antiviral acyclonucleoside 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine. tetrahedron lett 1985, 26, 4265-68.
Reference 2:
    grose, w.f.a.; pandit, u.k.; eggelte, t.a.; a new class of nucleoside analogues. synthesis of n1-pyrimidinyl- and n9-purinyl-4-hydroxy-3-(hydroxymethyl)butanes. synth commun 1972, 2, 345-351.
Reference 3:
    boyd, m.r.; jarvest, r.l.; bacon, t.h.; harnden, m.r.; synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines. j med chem 1987, 30, 1636-42.
Reference 4:
    hardern, d.n.; development of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines as potential therapeutic agents for treatment of human herpesvirus infections. drugs fut 1989, 14, 4, 347.
Reference 5:
    choudary, b.m.; geen, g.r.; kincey, p.m.; parratt, m.j.; dales, j.r.m.; johnson, g.p.; odonnell, s.; tudor, d.w.; woods, n.; a direct approach to the synthesis of famciclovir and penciclovir. nucleosides nucleotides 1996, 15, 5, 981.
Reference 6:
    harnden, m.r.; jarvest, r.l. (smithkline beecham plc); guanine derivs.. ep 0141927; es 8602791; es 8603887; es 8603888; jp 1994293764; us 5075445 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名喷昔洛韦;英文名Penciclovir;BRL-39123;Denavir;Vectavir;CAS[39809-25-1]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
2018年除草剂登记数量领先,
国光股份募集资金投资项目变更实
新农药登记需要注意哪些问题?
民族骄傲!氰烯菌酯再获国家科学
中山化工嘧菌酯/灭草松/啶酰菌
科迪华旗下喹禾灵除草剂产品线被
多个植保农药类项目拟提名201
BMS 白血病药物组合 Spr
年报!正邦科技净利润或同比下降
诺华镰状细胞病药物 Criza
农药领域的行政许可事项相互之间
增加至7000万!国光股份子公
hVIVO 启动通用流感疫苗
红太阳子公司重庆华歌生化投资设
预增!江山/新安2018年净利
吲唑磺菌胺化合物专利已经届满,
浙江地区醋酸价格
河北地区醋酸价格下调
暂停?不存在的!2019年将全
江苏省严查严管危废处置,保障环
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明